There are 2137 resources available
591P - Distress and perceived information among patients in phase I trials and their relatives: A prospective study
Presenter: Katrine Gad
Session: E-Poster Display
Resources:
Abstract
592P - A predictive score of antitumour activity of novel agents in cancer patients treated in early phase studies
Presenter: Runhan Liu
Session: E-Poster Display
Resources:
Abstract
593P - Longitudinal description of clinical trials for the development of cyclin-dependent kinases inhibitors
Presenter: Claudia Cardone
Session: E-Poster Display
Resources:
Abstract
594P - The Drug Rediscovery Protocol (DRUP): Results of the first 500 treated patients
Presenter: Louisa Hoes
Session: E-Poster Display
Resources:
Abstract
595P - Abdominal events in targeted therapies: Report from the Drug Rediscovery Protocol (DRUP)
Presenter: Laurien Zeverijn
Session: E-Poster Display
Resources:
Abstract
596TiP - Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours
Presenter: John Powderly
Session: E-Poster Display
Resources:
Abstract
597TiP - A phase Ib study on a TRPV6-inhibitor, SORC13 in patients with advanced solid tumours
Presenter: Siqing Fu
Session: E-Poster Display
Resources:
Abstract
598TiP - A phase I/Ib dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumours
Presenter: Jason Luke
Session: E-Poster Display
Resources:
Abstract
599TiP - BT8009-100 phase I/II study of the safety, pharmacokinetics, & preliminary clinical activity of BT8009 in patients with Nectin-4 expressing advanced malignancies
Presenter: Meredith Mckean
Session: E-Poster Display
Resources:
Abstract
600TiP - A first-in-human study of, NUC-7738, a 3'-dA phosphoramidate, in patients with advanced solid tumours (NuTide:701)
Presenter: Stefan Symeonides
Session: E-Poster Display
Resources:
Abstract